Clinical response to omalizumab in patients with hereditary α-tryptasemia
Lybil B. Mendoza Alvarez(University of Florida), Jonathan J. Lyons(University of California San Diego), Sarah C. Glover(Tulane University), Daniel Petroni(Allergy Asthma Research Institute), Jamie A. Rosenthal(University of Washington), Tom DiMaggio(National Institutes of Health), Celeste Nelson(National Institutes of Health), Joshua D. Milner(National Institute of Allergy and Infectious Diseases), Kelly D. Stone(National Institutes of Health), Russell Barker(Auckland City Hospital)
Cited by 29
Related Papers
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
|Clinical Gastroenterology and Hepatology|2012|492
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
|Nature Genetics|2016|393
Development of a consensus statement on the role of the family in the physical activity, sedentary, and sleep behaviours of children and youth
|International Journal of Behavioral Nutrition and Physical Activity|2020|340